Int J Med Sci 2020; 17(15):2240-2247. doi:10.7150/ijms.47555 This issue Cite

Research Paper

Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology

Shanshan Hu1*, Siteng Chen2*, Zhilei Li1, Yuhang Wang1, Yong Wang1,3✉

1. Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
2. Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
3. Laboratory of Research of New Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
*These authors contributed equally to this work.

Citation:
Hu S, Chen S, Li Z, Wang Y, Wang Y. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology. Int J Med Sci 2020; 17(15):2240-2247. doi:10.7150/ijms.47555. https://www.medsci.org/v17p2240.htm
Other styles

File import instruction

Abstract

Background: Chuanxiong Rhizoma is one of the traditional Chinese medicines which have been used for years in the treatment of diabetic nephropathy (DN). However, the mechanism of Chuanxiong Rhizoma in DN has not yet been fully understood.

Methods: We performed network pharmacology to construct target proteins interaction network of Chuanxiong Rhizoma. Active ingredients were acquired from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. DRUGBANK database was used to predict target proteins of Chuanxiong Rhizoma. Gene ontology (GO) biological process analyses and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were also performed for functional prediction of the target proteins. Molecular docking was applied for evaluating the drug interactions between hub targets and active ingredients.

Results: Twenty-eight target genes fished by 6 active ingredients of Chuanxiong Rhizoma were obtained in the study. The top 10 significant GO analyses and 6 KEGG pathways were enriched for genomic analysis. We also acquired 1366 differentially expressed genes associated with DN from GSE30528 dataset, including five target genes: KCNH2, NCOA1, KDR, NR3C2 and ADRB2. Molecular docking analysis successfully combined KCNH2, NCOA1, KDR and ADRB2 to Myricanone with docking scores from 4.61 to 6.28. NR3C2 also displayed good docking scores with Wallichilide and Sitosterol (8.13 and 8.34, respectively), revealing good binding forces to active compounds of Chuanxiong Rhizoma.

Conclusions: Chuanxiong Rhizoma might take part in the treatment of DN through pathways associated with steroid hormone, estrogen, thyroid hormone and IL-17. KCNH2, NCOA1, KDR, ADRB2 and NR3C2 were proved to be the hub targets, which were closely related to corresponding active ingredients of Chuanxiong Rhizoma.

Keywords: Diabetic Nephropathy, Chuanxiong Rhizoma, Network Pharmacology


Citation styles

APA
Hu, S., Chen, S., Li, Z., Wang, Y., Wang, Y. (2020). Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology. International Journal of Medical Sciences, 17(15), 2240-2247. https://doi.org/10.7150/ijms.47555.

ACS
Hu, S.; Chen, S.; Li, Z.; Wang, Y.; Wang, Y. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology. Int. J. Med. Sci. 2020, 17 (15), 2240-2247. DOI: 10.7150/ijms.47555.

NLM
Hu S, Chen S, Li Z, Wang Y, Wang Y. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology. Int J Med Sci 2020; 17(15):2240-2247. doi:10.7150/ijms.47555. https://www.medsci.org/v17p2240.htm

CSE
Hu S, Chen S, Li Z, Wang Y, Wang Y. 2020. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology. Int J Med Sci. 17(15):2240-2247.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image